Cell cultivation in an indispensable part for applications within medicine and scientific investigation. From simple substance test to cell therapies, cell technologies are completely based on the controlled propagation of cells. To achieve this goal non-invasive characterization of the cell population is to be established.
Microscope is the oldest piece of equipment required for cell culture but with the advances in technology, these are now automated microscopes combined with computerized image analysis. But image-based cytometry is much more capable than just describing cell cultures in terms of numbers.
The demand for image-based cytometer is expected to propel due to technological advancements, increasing use of image-based cytometer in clinical trials, development of intuitive software and the growing utilization of image-based flow cytometers in research activities.
The Jefferson Trust, awarded US$ 775,000 to universities to engage faculty and students in research. Mass Cytometry Antibody Bank was awarded US$ 35,000, q new technology which simultaneously measures 100 different cellular attributes of thousands of individual cells. The major hurdle for the researchers to access such technologies is the high cost related to buying antibodies.
Through this funding, this hurdle was overcame and could act as support for future donations.
High throughput screening is available in almost all the recent technologies introduced. This is because of the emerging trend towards precision medicine where each clinical trial is towards a specific cell. Thus cell analyzer are also developed such as they provide the researcher with multifunctional results of thousands of cells.
With the increasing research undertakings and the potential offered for the equipment related the demand for image-based cytometer market is expected to propel. Moreover, market players are expanding their presence by developing a new technology or by growing in emerging countries.
In terms of geography, image-based cytometer market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America is expected to remain the dominating region while Asia Pacific is expected to emerge as a fastest growing region. ChemoMetec A/S established its first international sales subsidiary in Australia to be closer to its customer and addressing the issues quickly.
Some of the image-based cytometer market participants are Invitrogen, ChemoMetec A/S, Nexcelom Bioscience LLC., Vala Sciences Inc., Merck KGaA, GE Healthcare, Yokogawa Electric Corporation and Thorlabs, Inc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
On the basis of application the image-based cytometer market can be segment as:
On the basis of end user the image-based cytometer market can be segment as:
Explore Similar Insights
Image-Based Cytometer Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
